cytosine has been researched along with EBV Infections in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Herpes simplex virus (HSV) reactivations are usually prevented by acyclovir (ACV) prophylaxis, whereas cidofovir (CDV) has been used off indication to manage AdV infections." | 7.83 | Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation. ( Edelmann, A; Hofmann, J; Kühl, JS; Sauerbrei, A; Voigt, S, 2016) |
| " Herpes simplex virus (HSV) reactivations are usually prevented by acyclovir (ACV) prophylaxis, whereas cidofovir (CDV) has been used off indication to manage AdV infections." | 3.83 | Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation. ( Edelmann, A; Hofmann, J; Kühl, JS; Sauerbrei, A; Voigt, S, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Smarz-Widelska, I | 1 |
| Mertowski, S | 1 |
| Mertowska, P | 1 |
| Korona-Głowniak, I | 1 |
| Hymos, A | 1 |
| Grywalska, E | 1 |
| Załuska, W | 1 |
| Takamatsu, H | 1 |
| Araki, R | 1 |
| Nishimura, R | 1 |
| Yachie, A | 1 |
| Espinoza, JL | 1 |
| Okumura, H | 1 |
| Yoshida, T | 1 |
| Kuzushima, K | 1 |
| Nakao, S | 1 |
| Voigt, S | 1 |
| Hofmann, J | 1 |
| Edelmann, A | 1 |
| Sauerbrei, A | 1 |
| Kühl, JS | 1 |
| Abdulkarim, B | 1 |
| Sabri, S | 1 |
| Zelenika, D | 1 |
| Deutsch, E | 1 |
| Frascogna, V | 1 |
| Klijanienko, J | 1 |
| Vainchenker, W | 1 |
| Joab, I | 1 |
| Bourhis, J | 1 |
| Wakisaka, N | 2 |
| Yoshizaki, T | 2 |
| Raab-Traub, N | 1 |
| Pagano, JS | 1 |
| Tan, HH | 1 |
| Goh, CL | 1 |
| Kondo, S | 1 |
| Murono, S | 1 |
| Shimizu, Y | 1 |
| Nakashima, M | 1 |
| Tsuji, A | 1 |
| Furukawa, M | 1 |
| Hänel, M | 1 |
| Fiedler, F | 1 |
| Thorns, C | 1 |
1 review available for cytosine and EBV Infections
| Article | Year |
|---|---|
Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Ad | 2006 |
7 other studies available for cytosine and EBV Infections
| Article | Year |
|---|---|
The Importance of Toll-like Receptor 9 Expression on Monocytes and Dendritic Cells in the Context of Epstein-Barr Virus Infection in the Immunopathogenesis of Primary Glomerulonephritis.
Topics: Cytosine; Dendritic Cells; Epstein-Barr Virus Infections; Glomerulonephritis, IGA; Glomerulonephriti | 2022 |
Epstein-Barr virus-associated leukemic lymphoma after allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Cidofovir; Cytosine; Epstein-Barr Virus Infections; Female; Hematopoietic Stem Ce | 2016 |
Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
Topics: Acyclovir; Adenoviridae; Adenovirus Infections, Human; Antibiotic Prophylaxis; Antiviral Agents; Chi | 2016 |
Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
Topics: Animals; Antiviral Agents; Apoptosis; bcl-2-Associated X Protein; Burkitt Lymphoma; Carcinoma; Caspa | 2003 |
Ribonucleotide reductase inhibitors enhance cidofovir-induced apoptosis in EBV-positive nasopharyngeal carcinoma xenografts.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cidofovir; Cytosine; Drug Interactions; Enzyme | 2005 |
Treatment of locally recurrent Epstein-Barr virus-associated nasopharyngeal carcinoma using the anti-viral agent cidofovir.
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Cidofovir; Cytosine; Epstein-Barr Virus Infections; | 2008 |
Anti-CD20 monoclonal antibody (Rituximab) and Cidofovir as successful treatment of an EBV-associated lymphoma with CNS involvement.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes; Cidofovir; Cyt | 2001 |